https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1515002/full
Frontiers | Molecular response of a patient with e19a2-positive chronic myeloid leukemia to...
ObjectiveChronic myeloid leukemia (CML) is a malignancy driven by the BCR::ABL1fusion gene, with the e19a2 transcript being a rare variant, accounting for 0....